SLS 65C FLUX

Hazard statements (CLP)

H302, H312, H336

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

OSHA Physical state Liquid. Odor Alcohol-like.

Principle Routes of Exposure

Eye contact. Inhalation. Ingestion.

Potential Acute Health Effects

Inhalation Can cause central nervous system (CNS) depression. Symptoms and signs include headache, dizziness, fatigue, muscular weakness, drowsiness and, in extreme cases, loss of consciousness. Irritating to respiratory system. May cause drowsiness. Ingestion Harmful if swallowed. Can cause central nervous system (CNS) depression. Aspiration hazard if swallowed. Can enter lungs and cause damage. Can cause dizziness, light- headedness, headache, nausea and blurred vision. Exposure to high levels may cause unconsciousness. May cause drowsiness. Can cause target organ damage. Ingestion may cause gastrointestinal irritation and diarrhea. Skin Irritating to skin. Harmful in contact with skin. This product contains material(s) that are absorbed through the skin. Can cause target organ damage. and symptoms similar to those listed under inhalation or ingestion. Skin inflammation is characterized by itching, scaling, reddening or, occasionally, blistering. Prolonged or repeated contact can defat the skin and lead to irritation, cracking and/or dermatitis. Eyes Severely irritating to eyes. Risk of serious damage to eyes. Adverse symptoms may include the following: redness, itching, swelling, pain Potential chronic health effects

Potential chronic health

Prolonged or repeated contact can defat the skin and lead to irritation, cracking and/or dermatitis. Adverse symptoms may include the following: Organic acid: Prolonged skin contact may cause dermatitits. May cause disorders of the autonomic nervous system. Target organs Contains material which causes damage to the following organs: eye, lens or cornea. Contains material which may cause damage to the following organs: kidneys, the nervous system, liver, mucous membranes, gastrointestinal tract, upper respiratory tract, skin, central nervous system (CNS), nose/sinuses. Carcinogenicity

Teratogenic Effects

No evidence. Developmental effects No conclusive data is available to indicate product or any component present at greater than 0.1% may cause developmental abnormalities. Fertility effects No conclusive data is available to indicate product or any component present at greater than 0.1% may impair fertility. Medical conditions Pre-existing skin and digestive disorders and disorders involving any other target organs aggravated by over- mentioned in this MSDS as being at risk may be aggravated by over-exposure to this exposure product.